183 related articles for article (PubMed ID: 29438784)
21. Regulatory effect of recombinant interleukin (IL)3 and IL4 on cytokine gene expression of bone marrow and peripheral blood mononuclear cells.
Brantschen S; Gauchat JF; De Weck AL; Stadler BM
Eur J Immunol; 1989 Nov; 19(11):2017-23. PubMed ID: 2480900
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of antibody-chemokine fusion proteins for tumor-targeting applications.
Hess C; Neri D
Exp Biol Med (Maywood); 2014 Jul; 239(7):842-852. PubMed ID: 24872435
[TBL] [Abstract][Full Text] [Related]
23. The Targeted Delivery of Interleukin 4 Inhibits Development of Endometriotic Lesions in a Mouse Model.
Quattrone F; Sanchez AM; Pannese M; Hemmerle T; Viganò P; Candiani M; Petraglia F; Neri D; Panina-Bordignon P
Reprod Sci; 2015 Sep; 22(9):1143-52. PubMed ID: 25850899
[TBL] [Abstract][Full Text] [Related]
24. Targeted delivery of interleukin-10 to chronic cardiac allograft rejection using a human antibody specific to the extra domain A of fibronectin.
Franz M; Doll F; Grün K; Richter P; Köse N; Ziffels B; Schubert H; Figulla HR; Jung C; Gummert J; Renner A; Neri D; Berndt A
Int J Cardiol; 2015 Sep; 195():311-22. PubMed ID: 26056964
[TBL] [Abstract][Full Text] [Related]
25. Alternatively Spliced EDA Domain of Fibronectin Is a Target for Pharmacodelivery Applications in Inflammatory Bowel Disease.
Bootz F; Schmid AS; Neri D
Inflamm Bowel Dis; 2015 Aug; 21(8):1908-17. PubMed ID: 25993691
[TBL] [Abstract][Full Text] [Related]
26. The antibody-mediated targeted delivery of interleukin-10 inhibits endometriosis in a syngeneic mouse model.
Schwager K; Bootz F; Imesch P; Kaspar M; Trachsel E; Neri D
Hum Reprod; 2011 Sep; 26(9):2344-52. PubMed ID: 21705369
[TBL] [Abstract][Full Text] [Related]
27. A novel synthetic naïve human antibody library allows the isolation of antibodies against a new epitope of oncofetal fibronectin.
Villa A; Lovato V; Bujak E; Wulhfard S; Pasche N; Neri D
MAbs; 2011; 3(3):264-72. PubMed ID: 21487243
[TBL] [Abstract][Full Text] [Related]
28. Design and characterisation of a novel interleukin-15 receptor alpha fusion protein and analysis of interleukin-15 complexation.
Schmid AS; Neri D
PLoS One; 2019; 14(7):e0219313. PubMed ID: 31348785
[TBL] [Abstract][Full Text] [Related]
29. A Novel Antibody-IL15 Fusion Protein Selectively Localizes to Tumors, Synergizes with TNF-based Immunocytokine, and Inhibits Metastasis.
Corbellari R; Stringhini M; Mock J; Ongaro T; Villa A; Neri D; De Luca R
Mol Cancer Ther; 2021 May; 20(5):859-871. PubMed ID: 33632875
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic efficacy of the F8-IL2 immunocytokine in a metastatic mouse model of lung adenocarcinoma.
Wieckowski S; Hemmerle T; Prince SS; Schlienger BD; Hillinger S; Neri D; Zippelius A
Lung Cancer; 2015 Apr; 88(1):9-15. PubMed ID: 25682318
[TBL] [Abstract][Full Text] [Related]
31. Granulocyte-colony stimulating factor, granulocyte-macrophage colony stimulating factor, PIXY-321, stem cell factor, interleukin-3, and interleukin-7: receptor binding and effects on clonogenic proliferation in acute lymphoblastic leukemia.
Drach D; Estrov Z; Zhao S; Drach J; Cork A; Collins D; Kantarjian H; Andreeff M
Leuk Lymphoma; 1994 Dec; 16(1-2):79-88. PubMed ID: 7535143
[TBL] [Abstract][Full Text] [Related]
32. The immunocytokine F8-IL2 improves the therapeutic performance of sunitinib in a mouse model of renal cell carcinoma.
Frey K; Schliemann C; Schwager K; Giavazzi R; Johannsen M; Neri D
J Urol; 2010 Dec; 184(6):2540-8. PubMed ID: 21030045
[TBL] [Abstract][Full Text] [Related]
33. A high-affinity human monoclonal antibody specific to the alternatively spliced EDA domain of fibronectin efficiently targets tumor neo-vasculature in vivo.
Villa A; Trachsel E; Kaspar M; Schliemann C; Sommavilla R; Rybak JN; Rösli C; Borsi L; Neri D
Int J Cancer; 2008 Jun; 122(11):2405-13. PubMed ID: 18271006
[TBL] [Abstract][Full Text] [Related]
34. Antibody-Based Targeted Delivery of Interleukin-22 Promotes Rapid Clinical Recovery in Mice With DSS-Induced Colitis.
Bootz F; Ziffels B; Neri D
Inflamm Bowel Dis; 2016 Sep; 22(9):2098-105. PubMed ID: 27482975
[TBL] [Abstract][Full Text] [Related]
35. Selective production of interleukin 3 (IL3) and granulocyte-macrophage colony-stimulating factor (GM-CSF) in vitro by murine L3T4+ T cells: lack of spontaneous IL3 and GM-CSF production by Ly-2-/L3T4- lpr subset.
Davignon JL; Kimoto M; Kindler V; De Kossodo S; Vassalli P; Izui S
Eur J Immunol; 1988 Sep; 18(9):1367-72. PubMed ID: 3139430
[TBL] [Abstract][Full Text] [Related]
36. Antibody-Based Delivery of Cytokine Payloads to Carbonic Anhydrase IX Leads to Cancer Cures in Immunocompetent Tumor-Bearing Mice.
Ziffels B; Stringhini M; Probst P; Fugmann T; Sturm T; Neri D
Mol Cancer Ther; 2019 Sep; 18(9):1544-1554. PubMed ID: 31213507
[TBL] [Abstract][Full Text] [Related]
37. Different tissue distribution properties for glycosylation variants of fusion proteins containing the p40 subunit of murine interleukin-12.
Bootz F; Venetz D; Ziffels B; Neri D
Protein Eng Des Sel; 2016 Oct; 29(10):445-455. PubMed ID: 27515704
[TBL] [Abstract][Full Text] [Related]
38. Antibody-based targeting of interferon-alpha to the tumor neovasculature: a critical evaluation.
Frey K; Zivanovic A; Schwager K; Neri D
Integr Biol (Camb); 2011 Apr; 3(4):468-78. PubMed ID: 21225052
[TBL] [Abstract][Full Text] [Related]
39. Comparative in vivo analysis of the atherosclerotic plaque targeting properties of eight human monoclonal antibodies.
Fiechter M; Frey K; Fugmann T; Kaufmann PA; Neri D
Atherosclerosis; 2011 Feb; 214(2):325-30. PubMed ID: 21167484
[TBL] [Abstract][Full Text] [Related]
40. A novel anti-cancer L19-interleukin-12 fusion protein with an optimized peptide linker efficiently localizes in vivo at the site of tumors.
Ongaro T; Matasci M; Cazzamalli S; Gouyou B; De Luca R; Neri D; Villa A
J Biotechnol; 2019 Feb; 291():17-25. PubMed ID: 30586544
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
